2m 2m 2m 2m 2m 2m 2m
Medifast (MED)
NYSE
$10.88-$0.14 (-1.27%)
Price as of Jun 23, 2026 4:10 PM EDT- $122.5MMarket Cap
- -17.21%1-Year Change
- Personal ServicesIndustry
Medifast (MED)
$10.88-$0.14 (-1.27%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 385.8M -35.96% | 602.5M -43.80% | 1.1B -32.94% | 1.6B +4.75% | |
Cost of Revenue | 110.6M -29.93% | 157.8M -46.71% | 296.2M -35.35% | 458.2M +14.97% | |
Gross Profit | 275.2M -38.11% | 444.6M -42.69% | 775.9M -31.97% | 1.1B +1.14% | |
Sales and Marketing Expense | 289.4M -34.49% | 441.7M -31.98% | 649.4M -32.04% | 955.6M +4.86% | |
Research and Development Expense | -48.0M -11.91% | -54.5M +1,085.63% | -4.6M +2.22% | -4.5M +2.27% | |
Depreciation and Amortization Expense | 14.2M +12.08% | 12.7M -3.05% | 13.1M +19.37% | 11.0M +61.19% | |
Total Operating Expenses | 289.4M -34.49% | 441.7M -31.98% | 649.4M -32.04% | 955.6M +4.86% | |
Operating Profit | -14.2M -593.85% | 2.9M -97.72% | 126.4M -31.60% | 184.8M -14.54% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | -701,000 +203.46% | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 +100.00% | -701,000 +203.46% | |
Total Nonoperating Income and Expense | 8.6M +843.23% | 909,000 -62.05% | 2.4M +420.62% | -747,000 +566.96% | |
Income before Taxes | -5.6M -248.90% | 3.8M -97.06% | 128.8M -30.02% | 184.1M -14.84% | |
Income Taxes | 13.0M +668.46% | 1.7M -94.23% | 29.4M -27.44% | 40.5M -22.28% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -18.7M -992.97% | 2.1M -97.90% | 99.4M -30.75% | 143.6M -12.48% | |
Net Income from Continuing Operations Applicable to Common | -5.6M -248.90% | 3.8M -97.06% | 128.8M -30.02% | 184.1M -14.84% | |
Basic EPS and Net Income | -1.70 -994.74% | 0.19 -97.92% | 9.13 -28.78% | 12.82 -8.49% | |
Diluted EPS and Net Income | -1.70 -994.74% | 0.19 -97.91% | 9.10 -28.52% | 12.73 -8.35% | |
Basic Weighted Average Shares | 11.0M +0.47% | 10.9M +0.42% | 10.9M -2.78% | 11.2M -4.36% | |
Diluted Weighted Average Shares | 11.0M +0.16% | 11.0M +0.38% | 10.9M -3.15% | 11.3M -4.55% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 89.3M -1.79% | 90.9M -3.72% | 94.4M +7.70% | 87.7M -15.83% | |
Short-Term Investments | 78.0M +9.18% | 71.4M +1,161.32% | 5.7M N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 167.3M +3.04% | 162.3M +62.18% | 100.1M +14.15% | 87.7M -19.95% | |
Total Current Assets | 201.7M -5.93% | 214.4M -4.30% | 224.0M +0.56% | 222.8M -27.40% | |
Accumulated Depreciation | 68.2M +16.93% | 58.3M +23.33% | 47.3M +18.44% | 39.9M +22.15% | |
Property and Plant and Equipment and Net | 31.2M -16.78% | 37.5M -27.09% | 51.5M -10.00% | 57.2M +1.88% | |
Total Long-Term Assets | 7.8M -19.02% | 9.7M -34.01% | 14.7M +17.61% | 12.5M +92.58% | |
Total Assets | 248.0M -12.75% | 284.2M -8.29% | 309.9M -1.99% | 316.2M -20.61% | |
Income Taxes Payable | 0 -100.00% | 1.5M N/A | 0 -100.00% | 428,000 -83.35% | |
Total Short-Term Debt | N/A N/A | N/A N/A | 0 N/A | N/A N/A | |
Total Current Liabilities | 43.0M -33.04% | 64.2M -30.49% | 92.3M -34.49% | 140.9M -17.04% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 6.1M -38.74% | 9.9M -38.35% | 16.1M -20.46% | 20.3M -22.08% | |
Total Liabilities | 49.1M -33.81% | 74.1M -31.66% | 108.4M -32.72% | 161.2M -17.71% | |
Retained Earnings | 158.3M -10.47% | 176.8M +1.22% | 174.6M +24.88% | 139.9M -26.52% | |
Total Stockholders Equity | 198.9M -5.33% | 210.1M +4.28% | 201.5M +29.95% | 155.0M -23.43% | |
Total Shares Outstanding | 11.0M +0.48% | 10.9M +0.39% | 10.9M +0.21% | 10.9M -6.21% | |
Cash Flow | |||||
Cash from Operating Activities | 6.9M -71.96% | 24.5M -83.42% | 147.7M -24.11% | 194.6M +105.80% | |
Capital Expenditures | 5.6M -24.68% | 7.5M +14.98% | 6.5M -61.14% | 16.7M -51.24% | |
Cash from Investing Activities | -7.9M -70.11% | -26.5M -56.56% | -61.0M +434.84% | -11.4M -60.73% | |
Dividends Paid | 195,000 -72.73% | 715,000 -99.02% | 73.0M +1.95% | 71.6M +12.16% | |
Cash from Financing Activities | -564,000 -62.77% | -1.5M -98.10% | -79.8M -60.02% | -199.6M +59.50% | |
Financials Ratio | |||||
Gross Margin | 71.33% -3.35% | 73.80% +1.98% | 72.37% +1.45% | 71.34% -3.45% | |
Operating Margin | -3.68% -871.22% | 0.48% -95.95% | 11.79% +1.99% | 11.56% -18.41% | |
Return on Assets | -7.02% -1,096.89% | 0.70% -97.78% | 31.76% -20.98% | 40.18% -17.39% | |
Return on Equity | -9.13% -998.52% | 1.02% -98.18% | 55.77% -30.56% | 80.31% -11.94% | |
Revenue Growth | -35.96% -17.89% | -43.80% +32.99% | -32.94% -793.40% | 4.75% -92.49% | |
Current Ratio | 4.69 +40.48% | 3.34 +37.68% | 2.43 +53.50% | 1.58 -12.49% | |
Cash Ratio | 2.08 +46.68% | 1.42 +38.51% | 1.02 +64.40% | 0.62 +1.47% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow